Evidence map›Paper›PMID 21135109›Full record

ArticleThe Journal of biological chemistry2011

Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Julia Barsony, Yoshihisa Sugimura, Joseph G Verbalis

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03371199 (The Effect of Normalization of Sodium on Bone Markers in Patients With Epilepsy. A Randomized Single-blinded Placebo-controlled Trial.), which is not on this map. Cited by 106 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 6 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03371199 nacompletednot on this mapstarted 2017, after this paper: background citation

The Effect of Normalization of Sodium on Bone Markers in Patients With Epilepsy. A Randomized Single-blinded Placebo-controlled Trial.

TypeinterventionalSponsorRigshospitalet, DenmarkRan2017 to 2018Enrolled21ConditionsHyponatremia, Metabolic Bone DiseaseArmsSodium chloride, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 6 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Chronic hyponatremia and skeletal vulnerability: bone loss, fragility fracture risk, and therapeutic uncertainties.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Fracture risks in patients with arginine vasopressin deficiency: a nationwide matched cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Julia BarsonyDivision of Endocrinology and Metabolism, Georgetown University, Washington, DC 20007, USA. jb394@georgetown.edu
Yoshihisa Sugimura
Joseph G Verbalis
Georgetown University · US

Funding

HYPONATREMIA-INDUCED OSTEOPOROSISR01AG029477 · NIA · GEORGETOWN UNIVERSITY · PI VERBALIS, JOSEPH G · 2008 to 2010
$1.2M
VITAMIN D RESISTANCE AND RELATED DISORDERSZ01DK060050 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI BARSONY, JULIANNA · 1995 to 2006
–
Intramural NIH HHS Z01 DK060050NIA NIH HHS R01 AG029477NIA NIH HHS R01-AG029477
6 · The paper itself

Abstract

Our recent animal and human studies revealed that chronic hyponatremia is a previously unrecognized cause of osteoporosis that is associated with increased osteoclast numbers in a rat model of the human disease of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We used cellular and molecular approaches to demonstrate that sustained low extracellular sodium ion concentrations ([Na(+)]) directly stimulate osteoclastogenesis and resorptive activity and to explore the mechanisms underlying this effect. Assays on murine preosteoclastic RAW 264.7 cells and on primary bone marrow monocytes both indicated that lowering the medium [Na(+)] dose-dependently increased osteoclast formation and resorptive activity. Low [Na(+)], rather than low osmolality, triggered these effects. Chronic reduction of [Na(+)] dose-dependently decreased intracellular calcium without depleting endoplasmic reticulum calcium stores. Moreover, we found that reduction of [Na(+)] dose-dependently decreased cellular uptake of radiolabeled ascorbic acid, and reduction of ascorbic acid in the culture medium mimicked the osteoclastogenic effect of low [Na(+)]. We also detected downstream effects of reduced ascorbic acid uptake, namely evidence of hyponatremia-induced oxidative stress. This was manifested by increased intracellular free oxygen radical accumulation and proportional changes in protein expression and phosphorylation, as indicated by Western blot analysis from cellular extracts and by increased serum 8-hydroxy-2'-deoxyguanosine levels in vivo in rats. Our results therefore reveal novel sodium signaling mechanisms in osteoclasts that may serve to mobilize sodium from bone stores during prolonged hyponatremia, thereby leading to a resorptive osteoporosis in patients with SIADH.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAnimalsAscorbic AcidCalciumCell LineDeoxyguanosineEndoplasmic ReticulumHumansHyponatremiaInappropriate ADH SyndromeMiceOsmosisOsteoclastsOsteoporosisOxidative StressRats8-Hydroxy-2'-DeoxyguanosineAscorbic AcidCalciumDeoxyguanosineSodium

Identifiers

PMID21135109
PMCPMC3060537
OpenAlexW1972565986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.